Literature DB >> 24074537

Managing female sexual dysfunction.

John E Buster1.   

Abstract

Female sexual dysfunctions (FSDs) range from short-term aggravations to major emotional disturbances adversely affecting family and workplace. This review highlights diagnosis and management of the four most widely diagnosed FSDs. It initially focuses on hypoactive sexual desire disorder (HSDD) as a driving force at the heart of all other FSDs; nothing happens without sexual desire. Successful resolution of HSDD frequently facilitates resolution of other disorders. Central to understanding HSDD is the impact of aging female sexual endocrinology and its effect on both prevalence and expression patterns of FSD. Advances in this field have enabled introduction of some the most effective treatments yet described for HSDD. Sexual arousal disorder, though commonly affected by the same factors as HSDD, is heavily associated with psychotropic drugs and mood elevators. Orgasmic disorder is frequently the downstream result of other sexual dysfunctions, particularly HSDD, or the result of a major psychosexual trauma. Successful management of the underlying disorder often resolves orgasmic disorder. Sexual pain disorder is frequently the result of a gynecologic disorder, such as endometriosis, that can be substantially managed through successful treatment of that disorder. This article ends with the article's most important note: how to initiate the conversation.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Female sexual dysfunction; sexual arousal disorder; sexual pain disorder

Mesh:

Year:  2013        PMID: 24074537     DOI: 10.1016/j.fertnstert.2013.08.026

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

Review 1.  Menopause and Sexuality.

Authors:  Kimberley Thornton; Judi Chervenak; Genevieve Neal-Perry
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09       Impact factor: 4.741

2.  Validation of a Mandarin Chinese version of the pelvic organ prolapse/urinary incontinence sexual questionnaire IUGA-revised (PISQ-IR).

Authors:  Hsuan Wang; Hui-Hsuan Lau; Man-Jung Hung; Wen-Chu Huang; Yong-Wen Zheng; Tsung-Hsien Su
Journal:  Int Urogynecol J       Date:  2015-05-31       Impact factor: 2.894

3.  Treatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options.

Authors:  Gabriela S Pachano Pesantez; Anita H Clayton
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-01-25

4.  The potential role of endometrial nerve fibers in the pathogenesis of pain during endometrial biopsy at office hysteroscopy.

Authors:  Attilio Di Spiezio Sardo; Pasquale Florio; Loredana Maria Sosa Fernandez; Germano Guerra; Marialuigia Spinelli; Costantino Di Carlo; Marco Filippeschi; Carmine Nappi
Journal:  Reprod Sci       Date:  2014-05-07       Impact factor: 3.060

5.  Understanding and treating vaginismus: a multimodal approach.

Authors:  Peter T Pacik
Journal:  Int Urogynecol J       Date:  2014-06-04       Impact factor: 2.894

Review 6.  Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care.

Authors:  Laura Buggio; Giussy Barbara; Federica Facchin; Maria Pina Frattaruolo; Giorgio Aimi; Nicola Berlanda
Journal:  Int J Womens Health       Date:  2017-05-02

Review 7.  Evaluation and Management of Hypoactive Sexual Desire Disorder.

Authors:  Anita H Clayton; Sheryl A Kingsberg; Irwin Goldstein
Journal:  Sex Med       Date:  2018-03-06       Impact factor: 2.491

Review 8.  A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes.

Authors:  Charmaine Rochester-Eyeguokan; Lisa Meade
Journal:  Diabetes Ther       Date:  2017-09-16       Impact factor: 2.945

9.  Autologous Platelet-Released Growth Factor and Sexual Dysfunction Amendment: A Pilot Clinical Trial of Successful Improvement Sexual Dysfunction after Pelvic Irradiation

Authors:  Atefeh Samaie Nouroozi; Ashraf Alyasin; Ashraf Malek Mohammadi; Nili Mehrdad; Seyed Asadollah Mousavi; Mohammad Vaezi; Atoosa Gharib; Ardeshir Ghavamzadeh; Saeed Mohammadi
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

Review 10.  Female sexual dysfunction: a focus on flibanserin.

Authors:  Nicole M Lodise
Journal:  Int J Womens Health       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.